Neutra Corp. income statement NTRR

Annual Quarterly

In fiscal 2023, which ended Jan 31, 2023, Neutra Corp. reported revenue of $67,996, down 26.1% from the year before. It recorded a net loss of $561,417. The operating loss came to $297,675, an operating margin of -437.8%. Over the twelve months ended Oct 31, 2023, revenue was $17,397 and the net loss was $473,832. Across the 4 fiscal years shown, revenue grew from $6,395 in fiscal 2020 to $67,996 in fiscal 2023, about 119.9% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2024 Oct 31, 2023	FY 2023 Jan 31, 2023	FY 2022 Jan 31, 2022	FY 2021 Jan 31, 2021	FY 2020 Jan 31, 2020	FY 2019 Jan 31, 2019	FY 2018 Jan 31, 2018	FY 2017 Jan 31, 2017	FY 2016 Jan 31, 2016	FY 2015 Jan 31, 2015	FY 2014 Jan 31, 2014
Revenue	0 -82.7%	0 -26.1%	0 +849.9%	0 +51.5%	0	—	—	—	—	—	—
Cost of revenue	0 -76.2%	0 -46.3%	0 +41.7%	0	—	—	—	—	—	—	—
Gross profit	0 -86.9%	0 +13.3%	0 +193.7%	-0	—	—	—	—	—	—	—
Selling, general and administrative	0 -43.5%	0 -55.2%	1 +22.6%	0 +3.5%	0 -76.6%	2 +944.3%	0 -55.8%	0 -64.2%	1 +62.9%	1 -34.2%	1
Operating income	-0 +36.7%	-0 +49.0%	-1 -21.9%	-0 -21.4%	-0 +76.9%	-2 -944.3%	-0 +55.8%	-0 +64.2%	-1 -62.9%	-1 +34.2%	-1
Other income (expense)	—	-0 -427.4%	-0 +18.1%	-0 +80.0%	-0 +58.2%	-1 -102.7%	-0 +28.5%	-0 -22.3%	-0	—	—
Pretax income	—	-1	—	—	—	—	—	—	—	—	—
Income tax	—	0	—	—	—	—	—	—	—	—	—
Net income	-0 -2.5%	-1 +11.3%	-1 -17.4%	-1 +22.5%	-1 +71.4%	-2 -368.1%	-1 +40.2%	-1 +39.8%	-1 +23.9%	-2 -50.7%	-1
Net income to common	-0 +2.9%	-1 +22.3%	-1 -27.8%	-1	—	—	—	—	—	—	—
Other measures
Depreciation and amortization	0 -22.0%	0 +1.4%	0 +153.7%	0	—	—	—	—	—	—	—
EBITDA	-0 +40.3%	-0 +56.7%	-1 -12.9%	-0	—	—	—	—	—	—	—
Interest coverage	-14.07x	-4.80x	-9.63x	-3.93x	-1.16x	-2.37x	-0.46x	-0.75x	-2.58x	-0.55x	-3.30x
Margins
Gross margin	46.15%	51.92%	33.87%	-343.32%	—	—	—	—	—	—	—
Operating margin	-1,457.11%	-437.78%	-634.23%	-4,941.31%	-6,164.89%	—	—	—	—	—	—
Pretax margin	—	-820.48%	—	—	—	—	—	—	—	—	—
Profit margin	-2,723.64%	-825.66%	-687.86%	-5,563.04%	-10,877.58%	—	—	—	—	—	—
EBITDA margin	-1,103.36%	-321.74%	-549.70%	-4,624.74%	—	—	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: NTRR (OTC)
Fiscal year ends: January 31
Incorporated in: WY
Headquarters: Houston, TX
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1512886

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.